Fig. 1.
Peripheral blood hematopoietic progenitor cells in patients treated with paclitaxel and carboplatin.
CFU assays were carried out as described before (pre), 5 hours after infusion (post), and on day +7 after treatment. CFU assays were set up. Pretreatment numbers were arbitrarily assigned a value of 100%. ■, CFU-Meg; ⋄, BFU-E; ○, CFU-GM. Data from 4 different patients are shown.